Detalhe da pesquisa
1.
Combined Connectomics, MAPT Gene Expression, and Amyloid Deposition to Explain Regional Tau Deposition in Alzheimer Disease.
Ann Neurol
; 95(2): 274-287, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37837382
2.
Determinants of cognitive and brain resilience to tau pathology: a longitudinal analysis.
Brain
; 146(9): 3719-3734, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36967222
3.
Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease.
Brain
; 146(4): 1592-1601, 2023 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36087307
4.
Longitudinal head-to-head comparison of 11C-PiB and 18F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-ß monoclonal antibodies in dominantly inherited Alzheimer's disease.
Eur J Nucl Med Mol Imaging
; 50(9): 2669-2682, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37017737
5.
Tau Positron-Emission Tomography in Former National Football League Players.
N Engl J Med
; 380(18): 1716-1725, 2019 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30969506
6.
Monoamine oxidase binding not expected to significantly affect [18F]flortaucipir PET interpretation.
Eur J Nucl Med Mol Imaging
; 49(11): 3797-3808, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35596745
7.
The impact of demographic, clinical, genetic, and imaging variables on tau PET status.
Eur J Nucl Med Mol Imaging
; 48(7): 2245-2258, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33215319
8.
The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects.
Brain
; 143(12): 3805-3815, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33439987
9.
A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia.
Brain
; 142(6): 1723-1735, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31009046
10.
Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
Brain
; 140(3): 748-763, 2017 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28077397
11.
Standardization of amyloid quantitation with florbetapir standardized uptake value ratios to the Centiloid scale.
Alzheimers Dement
; 14(12): 1565-1571, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30006100
12.
Quantitation of PET signal as an adjunct to visual interpretation of florbetapir imaging.
Eur J Nucl Med Mol Imaging
; 44(5): 825-837, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28064343
13.
Effectiveness of Florbetapir PET Imaging in Changing Patient Management.
Dement Geriatr Cogn Disord
; 44(3-4): 129-143, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28787712
14.
Effect of Amyloid Imaging on the Diagnosis and Management of Patients with Cognitive Decline: Impact of Appropriate Use Criteria.
Dement Geriatr Cogn Disord
; 41(1-2): 80-92, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26745445
15.
Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients.
Alzheimers Dement
; 12(2): 110-120, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26238576
16.
Quantification of 18F-florbetapir PET: comparison of two analysis methods.
Eur J Nucl Med Mol Imaging
; 42(5): 725-32, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25652817
17.
The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET.
Alzheimers Dement
; 11(1): 1-15.e1-4, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25443857
18.
PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer's disease and Lewy body disorders.
BMC Neurol
; 14: 79, 2014 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-24716655
19.
A review of the flortaucipir literature for positron emission tomography imaging of tau neurofibrillary tangles.
Brain Commun
; 6(1): fcad305, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38187878
20.
Combining plasma Aß and p-tau217 improves detection of brain amyloid in non-demented elderly.
Alzheimers Res Ther
; 16(1): 115, 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38778353